Trial Profile
Effect of simeprevir (SMV) and/or sofosbuvir (SOF) containing regimens in patients with chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Peginterferon alfa; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Jun 2015 New trial record
- 20 May 2015 Results presented at the 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.